Navigation Links
Roche to Acquire Ventana for $89.50 per share

dge work in advancing disease detection and treatment. Our diagnostics and pharmaceuticals businesses in the U.S. employ more than 20,000 people and generate approximately $10 billion in sales (including Genentech), accounting for about 40% of the Roche Group's global annual revenues.
For further information, please visit

All trademarks used or mentioned in this release are protected by law.

About Ventana Medical Systems

Ventana develops, manufactures, and markets instrument/reagent systems that automate tissue preparation and slide staining in clinical histology and drug discovery laboratories worldwide. The company's clinical systems are important tools used in the diagnosis and treatment of cancer and infectious diseases. Ventana's drug discovery systems are used to accelerate the discovery of new drug targets and evaluate the safety of new drug compounds. Visit the Ventana Medical Systems, Inc. website at

Further information

- All documents on the offer to Ventana's shareholders:

Contacts for Roche:

Roche Group Media Office

Phone: +41 61 688 8888 / e-mail:

- Daniel Piller (Head of Roche Group Media Office)

- Alexander Klauser

Brunswick Group (for U.S. media)

Phone: +1 212 333 3810

- Steve Lipin

- Nina Devlin

MacKenzie Partners (for U.S. investors)

Phone: +1 212 929 5500

-Larry Dennedy

-Bob Marese

Contacts for Ventana:

Sard Verbinnen & Co (for media)

Phone: +1 212 687 8080

Anna Cordasco

Brooke Morganstein

Innisfree M&A Incorporated (for investors)

Phone: +1 212 750 5833

SOURCE Roche; Ventana Medical Systems
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. Roche Extends Tender Offer for Ventana
2. Amic Signs Non-Exclusive License Agreement With Roche Diagnostics for Key Cardiac Marker NT-proBNP
3. Roche Files IND for Second Genmab Antibody
4. Fourth Genmab Antibody Developed Under Roche Collaboration to Enter Clinic
5. Roche to Nominate Independent Directors for Election at Ventanas 2008 Annual Stockholders Meeting
6. MacroChem to Present at Equities Magazine Conference December 7, 2007 in New York
7. Roche Diagnostics Launches CoaguChek XS Plus System to Provide New PT/INR Point-of-Care Solution for Non-Waived Anticoagulation Services
8. Kosan to Reacquire Epothilone Program From Roche
9. Phase I Results Announced for R1507 From Genmabs Collaboration With Roche
10. MacroChem Announces Michael Zasloff, M.D., Ph.D. Joins Companys Scientific Advisory Board
11. MacroChem To Participate in PIPEs Conference October 18th and 19th in New York City
Post Your Comments:
(Date:9/30/2014)... (PRWEB) September 30, 2014 Proove ... medicine, is excited to announce a new genetic test ... The Proove Pain Perception Test will provide physicians ... and why pain tolerance levels are stratified between individuals. ... identify whether a person has a genetic predisposition that ...
(Date:9/30/2014)... 30, 2014 Genedata, a ... drug discovery and related life science research, ... chosen Genedata Selector as its host-pathogen data ... FUNGITECT is a European consortium dedicated to ... via individualized anti-fungal drug therapies. Genedata Selector ...
(Date:9/30/2014)... MA (PRWEB) September 30, 2014 iLab ... Facility Management Benchmarking study which focuses on core ... common challenges core managers face today. , In its ... revealed. One of note is the year-over-year decrease in ... Core managers appear to be feeling the constraints of ...
(Date:9/30/2014)... Rainbow Scientific, Inc. (RSI), a ... opened an online store to add customer convenience ... developed and manufactured by Biological Industries, Inc. , ... Industries’ Nutristem® serum-free, xeno-free reagents for human mesenchymal ... (hESC) culture. , The online store also ...
Breaking Biology Technology:Proove Biosciences is Now Offering the Proove Pain Perception Genetic Test to Help Physicians Assess Patient Pain Tolerance Levels 2Proove Biosciences is Now Offering the Proove Pain Perception Genetic Test to Help Physicians Assess Patient Pain Tolerance Levels 3FUNGITECT Consortium Adopts Genedata Selector as Data Analysis Platform for Anti-fungal R 2FUNGITECT Consortium Adopts Genedata Selector as Data Analysis Platform for Anti-fungal R 3iLab Solutions Announces the Results of the 2014 Core Facility Benchmarking Study 2iLab Solutions Announces the Results of the 2014 Core Facility Benchmarking Study 3Rainbow Scientific, Inc. opens online store for state-of-the-art stem cell culture and cytogenetic reagents 2
... BERKELEY, Calif., Sept. 18 Dynavax,Technologies Corporation (Nasdaq: ... and Chief Financial Officer, will present an overview ... Sciences Conference in New York, New,York on Tuesday, ... Time,(6:30 a.m. PDST). The presentation will be webcast. ...
... Increasing Global Need for Genzyme Products, CAMBRIDGE, Mass., ... broke ground on a significant expansion of its,flagship manufacturing ... is focused on adding space for manufacturing support,functions, and ... The expansion was marked by a ceremony featuring Massachusetts ...
... Biopharmaceuticals Plc, a,private biopharmaceutical company focusing on ... it has,appointed Rosemary Mazanet M.D., Ph.D. as ... significant experience in both executive and,operational management ... serves on the Board of numerous private ...
Cached Biology Technology:Dynavax to Present at UBS 2007 Global Life Sciences Conference 2Genzyme Begins Major Expansion of Boston Manufacturing Facility 2Genzyme Begins Major Expansion of Boston Manufacturing Facility 3Genzyme Begins Major Expansion of Boston Manufacturing Facility 4Genzyme Begins Major Expansion of Boston Manufacturing Facility 5Morria Biopharmaceuticals Plc Announces Appointment of Dr. Rosemary Mazanet as Interim Chief Executive Officer 2
(Date:9/30/2014)... Researchers of Ludwig-Maximilians-Universitaet (LMU) in Munich report that ... cells more sensitive to chemotherapeutic drugs. They have ... a new target for anti-tumor agents. , ... Professor Stephan Sieber of the Technische Universitt Mnchen ... a potential new weapon in the fight against ...
(Date:9/30/2014)... threats in today,s ocean. From overfishing and pollution ... ecosystems are disappearing at unprecedented rates around the ... surrounding the island of Moorea in French Polynesia ... coral guard-crabs. New research from the National Museum ... McKeon and the museum,s predoctoral fellow Jenna Moore ...
(Date:9/29/2014)... Plants have a symbiotic relationship with certain bacteria. ... and defend against invaders an important step ... Now, scientist have discovered that plants may package ... that sprouting plants are colonized from the beginning. ... presented their findings today at the 5th ASM ...
Breaking Biology News(10 mins):Cancer therapy: Driving cancer cells to suicide 2Smithsonian scientists discover coral's best defender against an army of sea stars 2Plants prepackage beneficial microbes in their seeds 2
... German Center for Neurodegenerative Diseases (DZNE) and the University ... "NLRP3 inflammasome" is composed of several proteins and plays ... a fire alarm sensor that triggers a chain reaction ... and substances that foster inflammation are released. This process ...
... 19, 2012) -- A new report in the journal ... vast, understudied swath of the animal kingdom that includes as ... genomes of a leech, an ocean-dwelling worm and a kind ... University, the University of California-Berkeley and the Department of Energy,s ...
... that badgers which strayed away from the family burrow in favour ... The 12-month study of 40 wild badgers was funded ... could have implications for the management of bovine TB in parts ... be a key factor in how the disease is spread among ...
Cached Biology News:Alzheimer's disease: Cutting off immune response promises new approach to therapy 2Genomic frontier: The unexplored animal kingdom 2Genomic frontier: The unexplored animal kingdom 3Badger sleeping habits could help target TB control 2
... Radiochemical Purity is >95%NEN Radiolabeled Ligands\n\nReceptor-related research ... availability of new radiolabeled ligands selected to ... a wide range of products and services ... over 400 state-of-the-art radioligands. If you do ...
... The Polymerase gene from Thermus ... expressed in E. coli, then highly ... It is used in the amplification ... PCR. The quality of the Taq ...
Request Info...
... iTaq DNA polymerase is ... suitable for both conventional and ... is supplied at a concentration ... and includes 250 units polymerase, ...
Biology Products: